AMANDA RUSSO: Open Payments
NPI 1952881229 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 26 payments from 10 companies in 2025. Trend: 2023 $836 · 2024 $2,016 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 7 | $179 |
| CVRx, Inc. | 1 | $158 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| Novo Nordisk Inc | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $34 |
| Regeneron Pharmaceuticals, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Attruby, Barostim Neo System, VERQUVO, Wegovy, LifeVest, EVKEEZA, Ozempic, CAPVAXIVE.
Industry payments across TX — which companies pay providers there.
